Paradigm Biopharmaceuticals

Pharmaceutical Manufacturing, Antiseptics and antibacterial preparations, Health, medical and pharmaceutical · 11 Employees
Phone Number: +61 3 9629 5566
Email Address: info@paradigmbiopharma.com
  • Overview
  • Employees
Access 21 Verified Employees Profiles for Paradigm BiopharmaceuticalsUnlock Free Contacts Now
About
Paradigm’s (ASX:PAR) immediate commercial focus is the development of pentosan polysulfate sodium (PPS) for the treatment of osteoarthritis (OA). This is a global unmet need and we have advanced to phase 3 trials in the space. Addressing all aspects of the disease: inflammation, pain, and regeneration, the non-opioid PPS has genuine disease-modifying potential.
Year Founded
2014
Social Media
Linkedin
Industry
Pharmaceutical Manufacturing, Antiseptics and antibacterial preparations, Health, medical and pharmaceutical, Chemicals, Pharmaceuticals & Plastics, Pharmaceutical preparations NES, Pharmaceutical preparations for the central and autonomic nervous system and anaesthetics, Pharmaceutical preparations for the cardiovascular system
HQ Location
500 collins L2 517 Flinders Lane Melbourne, Victoria 3000, AU
Keywords
--
Location
  • 500 collins L2 517 Flinders Lane Melbourne, Victoria 3000, AU

Email Formats

Sign up for free credits and discover verified email addresses of Paradigm Biopharmaceuticals
FormatExamples
first + last
andywarhol@paradigmbiopharma.com
first_initial + last
awarhol@paradigmbiopharma.com
first + last_initial
andyw@paradigmbiopharma.com
first
andy@paradigmbiopharma.com
last
warhol@paradigmbiopharma.com
Get Verified Emails for 21 Paradigm Biopharmaceuticals Employees

Frequently Asked Questions

Learn More about Paradigm Biopharmaceuticals

Similar Companies

Pharmaceutical Manufacturing, Antiseptics and antibacterial preparations, Health, medical and pharmaceutical

Get key business info for Paradigm Biopharmaceuticals and other 100M companies. Start your seach.

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.